Physician

Maqbool Alam Halepota, M.D.

According to 2025 Medicare claims, Maqbool Halepota, M.D. (NPI: 1558384966) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is PALO VERDE HEMATOLOGY ONCOLOGY LTD. (NPI: 1447272372; TIN: 860416050) and primary practice location at 85251-4548. Halepota is affiliated with the Banner Health Network (ACO ID: A3229), participating under the MSSP model.

Halepota's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 318,005 HCPCS/CPT codes, and received $4,353,863 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 713 prescription claims across 148 beneficiaries totaling $2,156,179 in drug costs, led by Venclexta (Venetoclax). DME data shows 33 claims. Open Payments data shows 43 records totaling $1,087. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,393,225 and ending at $2,156,179. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,343 to $1,201.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	547	282,431	$4,116,969
2016	578	250,239	$3,999,413
2017	630	266,094	$4,080,611
2018	587	217,681	$3,658,015
2019	616	304,737	$5,004,995
2020	541	342,316	$5,421,098
2021	520	297,169	$4,040,041
2022	519	282,086	$3,866,348
2023	492	302,946	$3,830,562
2024	461	318,005	$4,353,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	207	1,163	$1,393,225
2016	220	1,099	$1,501,644
2017	210	1,034	$1,177,337
2018	195	981	$1,135,700
2019	200	1,060	$1,115,768
2020	198	1,011	$1,375,679
2021	209	936	$1,863,459
2022	164	803	$1,135,654
2023	141	626	$1,465,240
2024	148	713	$2,156,179

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	65	$19,967
2016	N/R	43	$13,624
2017	N/R	13	$1,095
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$1,157
2021	N/R	14	$1,476
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	33	$27,653

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	79	137	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	361	1,282	$94
96372	Injection of drug or substance under skin or into muscle	77	604	$11
36415	Insertion of needle into vein for collection of blood sample	298	1,163	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	310	1,550	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Venclexta	Venetoclax	61	1,756	$545,257
Xtandi	Enzalutamide	26	780	$378,538
Calquence	Acalabrutinib Maleate	14	420	$192,757
Jakafi	Ruxolitinib Phosphate	14	420	$180,671
Xgeva	Denosumab	30	910	$95,023

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4197	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix	N	N/R	11	$21,433
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	11	$4,303
B4224	Parenteral nutrition administration kit, per day	N	N/R	11	$1,916

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,087	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maqbool Alam Halepota, M.D.?

Tedicare shows public-source Medicare data for Maqbool Alam Halepota, M.D. (NPI 1558384966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maqbool Alam Halepota, M.D. have ACO affiliation data?

Maqbool Alam Halepota, M.D. is shown with ACO affiliation data for Banner Health Network (MSSP, ACO ID A3229).

What billing organization is linked to Maqbool Alam Halepota, M.D.?

Maqbool Alam Halepota, M.D. is linked to PALO VERDE HEMATOLOGY ONCOLOGY LTD. (billing NPI 1447272372) in the available physician profile data.

Does Maqbool Alam Halepota, M.D. have Open Payments data?

Maqbool Alam Halepota, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.